As early as 1989 HÄMOSAN has been intensively involved in TSE research (Transmissible Spongiforme Encephalopathies) and has acquired a pioneer status in the field.
Herwig Reichl and his team offer this very specific expertise to international companies in the pharmaceutical and biotech industries and to the human blood fractionation industry. The planning and validation of production processes regarding the risks of prion infections have become an important topic: TSE (eg. BSE in cattle, Scrapie in sheep, Creutzfeld-Jacob-Disease in human beings).
HÄMOSAFE services in more detail
Please call or email for more information:
Legal notice, © Copyright 1998-2015 HÄMOSAN Life Science Services® GmbH